- Home
- ALTS vs NKTR Comparison
ALTS vs NKTR Comparison
Compare ALTS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- NKTR
- Stock Information
- Founded
- ALTS 1976
- NKTR 1990
- Country
- ALTS United States
- NKTR United States
- Employees
- ALTS N/A
- NKTR N/A
- Industry
- ALTS
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- NKTR Health Care
- Exchange
- ALTS NYSE
- NKTR Nasdaq
- Market Cap
- ALTS 125.5M
- NKTR 108.3M
- IPO Year
- ALTS N/A
- NKTR 1994
- Fundamental
- Price
- ALTS $7.08
- NKTR $25.00
- Analyst Decision
- ALTS
- NKTR Strong Buy
- Analyst Count
- ALTS 0
- NKTR 6
- Target Price
- ALTS N/A
- NKTR $81.67
- AVG Volume (30 Days)
- ALTS 291.0K
- NKTR 1.5M
- Earning Date
- ALTS 08-18-2025
- NKTR 08-07-2025
- Dividend Yield
- ALTS N/A
- NKTR N/A
- EPS Growth
- ALTS N/A
- NKTR N/A
- EPS
- ALTS N/A
- NKTR N/A
- Revenue
- ALTS $18,046,000.00
- NKTR $87,248,000.00
- Revenue This Year
- ALTS $185.91
- NKTR N/A
- Revenue Next Year
- ALTS $64.93
- NKTR N/A
- P/E Ratio
- ALTS N/A
- NKTR N/A
- Revenue Growth
- ALTS N/A
- NKTR N/A
- 52 Week Low
- ALTS $1.29
- NKTR $6.48
- 52 Week High
- ALTS $10.95
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- ALTS 42.65
- NKTR 60.49
- Support Level
- ALTS $7.27
- NKTR $23.56
- Resistance Level
- ALTS $7.60
- NKTR $26.35
- Average True Range (ATR)
- ALTS 0.66
- NKTR 2.02
- MACD
- ALTS -0.04
- NKTR -0.50
- Stochastic Oscillator
- ALTS 30.97
- NKTR 53.50
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.